Navigation Links
Pharmaxis Announces Positive Combined Phase 3 Cystic Fibrosis Trial Results
Date:10/22/2010

sive treatment with antibiotics that is now common practice in the clinic.  Despite this, Bronchitol produced a clinically relevant reduction in exacerbations in patients completing the study, and together with recent data showed sustained benefit in lung function out beyond 18 months."

Other results from CF302 presented at the NACF conference underlined both the good safety profile of Bronchitol and patient adherence.  Overall adverse events on Bronchitol were similar to those experienced on control with 7% of patients taking Bronchitol withdrawing due to adverse events compared to 4% of patients on control.  There was no increase in the numbers of bacteria present in the lungs.  The most commonly reported adverse event related to treatment was cough occurring in 6% of the Bronchitol group and 3.3% of the control group.

Moira Aitken, M.D., F.R.C.P. (Edin), Professor of Medicine, Division of Pulmonary and CCM, University of Washington, and lead principal investigator of CF302, stated, "We are excited by the results of the Bronchitol Phase III clinical program.  Across both trials, inhaled mannitol was well tolerated and demonstrated an early and sustained improvement in lung function.  This improvement in FEV1 was achieved on top of aggressive use of concomitant medications such as inhaled antibiotics and rhDNase.  These results, coupled with Bronchitol's novel formulation and portable dry powder inhaler administration, suggest that it will have a significant impact on CF patient well-being."

These conclusions were echoed by participants in CF302:

In treating CF, I take a lot of medications.  Some are pills, like different antibiotics, and some are nebulizers or inhalers such as Albuterol, Pulmozyme.  One in particular – tobramycin – I took when I was sick, but after taking Bronchitol I was able to stop that because it made such a huge difference in my pulmonary function test. K.
'/>"/>

SOURCE Pharmaxis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. FDA Approves Pharmaxis ARIDOL™ (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness
2. Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial
3. Pharmaxis Announces Milestone in Phase III Trial for Cystic Fibrosis
4. Pharmaxis Announces New Drug Application Submission for Aridol(TM)
5. ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia
6. Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial
7. Pharmaxis Establishes Named Patient Program for Bronchitol
8. Pharmaxis Long-Term Safety Study of Bronchitol Completes
9. Boston Scientific Announces CE Mark Approval for Expanded Indication of WallFlex® Biliary RX Stent
10. Warner Chilcott Announces FDA Approval of New Oral Contraceptive
11. Repligen Announces Conference Call of Second Quarter Fiscal Year 2011 Results Tuesday, November 2nd, 3:00 p.m. EDT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , August 29, 2014 Pixcelldata, ... collaboration software has announced a major new deal with ... by renowned pathology expert, Dr. Marius Nap . ... the 26th European Congress of Pathology which is taking ... ExCeL Arena, London where Pixcelldata ...
(Date:8/28/2014)... Reportlinker.com announces that a new market research report ... America Aesthetic Lasers and Energy Devices Market Outlook ... North America Aesthetic Lasers and Energy ... GlobalData,s new report, "North America Aesthetic Lasers and ... market data on the North America Aesthetic Lasers ...
(Date:8/28/2014)... 2014 Reportlinker.com announces that a new ... Germany Aesthetic Lasers and Energy Devices ... http://www.reportlinker.com/p02343442/Germany-Aesthetic-Lasers-and-Energy-Devices-Market-Outlook-to-2020.html Germany Aesthetic Lasers and ... GlobalData,s new report, "Germany Aesthetic Lasers and ... market data on the Germany Aesthetic Lasers and ...
Breaking Medicine Technology:Pixcelldata Announces New Deal with Dutch Tele-Pathology Specialists eX-Path Ahead of ECP 2014 2North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 2North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 3North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 4North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 5North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 6North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 7North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 8North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 9North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 10North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 11North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 12North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 13North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 14North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 15North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 16Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 2Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 3Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 4Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 5Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 6Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 7Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 8Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 9
... , , , , , , , ... 15 /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, Inc. ("China Sky ... fully integrated pharmaceutical company developing and producing,over-the-counter drugs in ... Company has relocated its headquarters to its new buildings,in the ...
... , GREENVILLE, S.C. , Jan. 14 ... online, real-time webcast and rebroadcast of its conference call on ... first quarter of fiscal 2010, which will be released after the ... broadcast of Span-America,s conference call will be available online at ...
Cached Medicine Technology:China Sky One Medical, Inc. Completes and Moves into New Corporate Headquarters 2China Sky One Medical, Inc. Completes and Moves into New Corporate Headquarters 3Span-America Announces First Quarter Conference Call On The Internet 2
(Date:8/29/2014)... new report released yesterday by the Mental Health ... mental health training and education that police personnel ... prominent issue for Canada,s police community, and today,s ... law enforcement and people with mental illnesses," says ... with an interest in the area of police ...
(Date:8/29/2014)... AURORA, Colo. (Sept. 2, 2014) A team of ... has reported the breakthrough discovery of a process to ... patients. These findings could have implications that extend beyond ... and autoimmune diseases., In an article published ... the Charles C. Gates Center for Regenerative Medicine and ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 LiveOps, Inc., ... service solutions, today announced that LiveOps has been selected ... Association's (MDA) Show of Strength Telethon for the third ... raises money and awareness to support MDA’s mission to ... aggressive and sometimes fatal muscle disease. This year’s program ...
(Date:8/29/2014)... Steven Reinberg HealthDay Reporter ... The vast majority of American babies are getting the ... federal health officials said Thursday. More than 90 ... measles, mumps, and rubella (MMR); polio; hepatitis B and ... Control and Prevention. "Nationally, vaccination among children 19 ...
(Date:8/29/2014)... Pittsburgh, PA (PRWEB) August 29, 2014 ... be slippery, especially when wearing socks. Also, many patients ... ambulatory problems, poor balance, surgery recovery, Alzheimer’s, etc. Two ... in order to optimize patient safety. , This special ... medical-facility floors. It also keeps patients who are relegated ...
Breaking Medicine News(10 mins):Health News:Report advocates improved police training 2Health News:CU scientists' discovery could lead to new cancer treatment 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 3Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 4Health News:Most U.S. Babies Get Their Vaccines: CDC 2Health News:Most U.S. Babies Get Their Vaccines: CDC 3
... drug advertisements are appearing on television, the bulk ... companies spend annually to market their products is ... medical students. , A literature review by ... and the Regenstrief Institute, Inc. published in the ...
... study suggests it boosts production of bone-eroding cells , , MONDAY, ... by millions of diabetes patients, may contribute to bone loss, ... fear that, over the long term, Avandia (rosiglitazone) may speed ... dangerous and even fatal fractures. , The findings appear in ...
... was one of the,five deadliest storms in United ... $86 billion.) The total fatalities were estimated at ... the West Coast, CJ (of CJ,s Functional,Fitness) has ... techniques, with,old school parental inspirations, to counsel the ...
... trigger symptoms, experts warn , SATURDAY, Dec. 1 (HealthDay News) ... the season of sneezing, congestion and other woes for people ... the American Academy of Allergy, Asthma & Immunology (AAAAI). , ... they say. , "Whether it,s feasting on holiday meals, setting ...
... The third annual,Saddleback Global Summit on AIDS & The Church ... to the more than 1,700 attendees for,the Church to lead ... with HIV/AIDS need to have the invisible God made visible ... are many things we,don,t know about this epidemic, but what ...
... 30 A recent press release,incorrectly attributed findings ... out-of-pocket expenses of family caregivers. Today,SarahCare issued the ... recent press release issued by SarahCare corporate did ... taken from the "Evercare(R)/NAC,Study of Caregivers -- What ...
Cached Medicine News:Health News:Do medical schools affect the way future doctors interact with drug companies? 2Health News:Diabetes Drug Avandia Could Weaken Bones 2Health News:CJ Transforms His Functional Fitness Program Into an Additional Resource for the Hurricane Katrina Survivors 2Health News:CJ Transforms His Functional Fitness Program Into an Additional Resource for the Hurricane Katrina Survivors 3Health News:'Tis the Season For Allergy, Asthma 2Health News:Global Summit on AIDS & The Church Calls for Public, Private and Parish Sectors To Unite in Response to Worldwide Pandemic: Pastor Rick and Kay Warren Host More Than 1,700 at Event Featuring International Dignitaries, Political Figures and International E 2Health News:Global Summit on AIDS & The Church Calls for Public, Private and Parish Sectors To Unite in Response to Worldwide Pandemic: Pastor Rick and Kay Warren Host More Than 1,700 at Event Featuring International Dignitaries, Political Figures and International E 3
... Series II Power Supplies. The EPS-2000-II, ... EPS-6000-II. These high-voltage power supplies offer ... power operating modes, with automatic crossover ... current/300 watts maximum power (except for ...
... power supply, 100-120 and 220-240 V, provides ... 1-500 W. The two-line, 16-character LCD allows ... of run progress. Built-in infrared capability allows ... a built-in switch when using either electrical ...
... PowerPac Basic power supply, 100-120 ... of 10-300 V, 4-400 mA, ... contains a built-in switch when ... the appropriate power cord. Power ...
... PRODUCT SPECIFICATIONS Form: Granular, free flowing powder EEO(-m r ... Point (3%): less than or equal to 31C ... 76C Gel Strength (3%): greater than or equal to ... or equal to 1000 gm/cm 2 Moisture: less ...
Medicine Products: